UBS (Lux) Equity Fund - Biotech Q Fonds
122,03
EUR
-0,22
EUR
-0,18
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 9,89% |
| Gilead Sciences Inc | US3755581036 | 4,49% |
| Ionis Pharmaceuticals Inc | US4622221004 | 4,48% |
| Insmed Inc | US4576693075 | 4,18% |
| Amgen Inc | US0311621009 | 3,86% |
| Roivant Sciences Ltd Ordinary Shares | BMG762791017 | 3,85% |
| Arrowhead Pharmaceuticals Inc | US04280A1007 | 3,58% |
| Denali Therapeutics Inc | US24823R1059 | 3,42% |
| AbbVie Inc | US00287Y1091 | 3,11% |
| Royalty Pharma PLC Class A | GB00BMVP7Y09 | 3,09% |
| Sonstige | 56,05% |